CD44 regulates hepatocyte growth factor-mediated vascular integrity

Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin

Patrick A. Singleton, Ravi Salgia, Liliana Moreno-Vinasco, Jaideep Moitra, Saad Sammani, Tamara Mirzapoiazova, Joe GN Garcia

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

The preservation of vascular endothelial cell (EC) barrier integrity is critical to normal vessel homeostasis, with barrier dysfunction being a feature of inflammation, tumor angiogenesis, atherosclerosis, and acute lung injury. Therefore, agents that preserve or restore vascular integrity have important therapeutic implications. In this study, we explored the regulation of hepatocyte growth factor (HGF)-mediated enhancement of EC barrier function via CD44 isoforms. We observed that HGF promoted c-Met association with CD44v10 and recruitment of c-Met into caveolin-enriched microdomains (CEM) containing CD44s (standard form). Treatment of EC with CD44v10-blocking antibodies inhibited HGF-mediated c-Met phosphorylation and c-Met recruitment to CEM. Silencing CD44 expression (small interfering RNA) attenuated HGF-induced recruitment of c-Met, Tiam1 (a Rac1 exchange factor), cortactin (an actin cytoskeletal regulator), and dynamin 2 (a vesicular regulator) to CEM as well as HGF-induced trans-EC electrical resistance. In addition, silencing Tiam1 or dynamin 2 reduced HGF-induced Rac1 activation, cortactin recruitment to CEM, and EC barrier regulation. We observed that both HGF- and high molecular weight hyaluronan (CD44 ligand)-mediated protection from lipopolysaccharide-induced pulmonary vascular hyperpermeability was significantly reduced in CD44 knock-out mice, thus validating these in vitro findings in an in vivo murine model of inflammatory lung injury. Taken together, these results suggest that CD44 is an important regulator of HGF/c-Met-mediated in vitro and in vivo barrier enhancement, a process with essential involvement of Tiam1, Rac1, dynamin 2, and cortactin.

Original languageEnglish (US)
Pages (from-to)30643-30657
Number of pages15
JournalJournal of Biological Chemistry
Volume282
Issue number42
DOIs
StatePublished - Oct 19 2007
Externally publishedYes

Fingerprint

Dynamin II
Cortactin
Hepatocyte Growth Factor
Blood Vessels
Endothelial cells
Caveolins
Endothelial Cells
Phosphorylation
Blocking Antibodies
Acoustic impedance
Acute Lung Injury
Lung Injury
Hyaluronic Acid
Electric Impedance
Knockout Mice
Small Interfering RNA
Lipopolysaccharides
Actins
Tumors
Atherosclerosis

ASJC Scopus subject areas

  • Biochemistry

Cite this

CD44 regulates hepatocyte growth factor-mediated vascular integrity : Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. / Singleton, Patrick A.; Salgia, Ravi; Moreno-Vinasco, Liliana; Moitra, Jaideep; Sammani, Saad; Mirzapoiazova, Tamara; Garcia, Joe GN.

In: Journal of Biological Chemistry, Vol. 282, No. 42, 19.10.2007, p. 30643-30657.

Research output: Contribution to journalArticle

Singleton, Patrick A. ; Salgia, Ravi ; Moreno-Vinasco, Liliana ; Moitra, Jaideep ; Sammani, Saad ; Mirzapoiazova, Tamara ; Garcia, Joe GN. / CD44 regulates hepatocyte growth factor-mediated vascular integrity : Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. In: Journal of Biological Chemistry. 2007 ; Vol. 282, No. 42. pp. 30643-30657.
@article{630df4c831734965b0216a9d488356e1,
title = "CD44 regulates hepatocyte growth factor-mediated vascular integrity: Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin",
abstract = "The preservation of vascular endothelial cell (EC) barrier integrity is critical to normal vessel homeostasis, with barrier dysfunction being a feature of inflammation, tumor angiogenesis, atherosclerosis, and acute lung injury. Therefore, agents that preserve or restore vascular integrity have important therapeutic implications. In this study, we explored the regulation of hepatocyte growth factor (HGF)-mediated enhancement of EC barrier function via CD44 isoforms. We observed that HGF promoted c-Met association with CD44v10 and recruitment of c-Met into caveolin-enriched microdomains (CEM) containing CD44s (standard form). Treatment of EC with CD44v10-blocking antibodies inhibited HGF-mediated c-Met phosphorylation and c-Met recruitment to CEM. Silencing CD44 expression (small interfering RNA) attenuated HGF-induced recruitment of c-Met, Tiam1 (a Rac1 exchange factor), cortactin (an actin cytoskeletal regulator), and dynamin 2 (a vesicular regulator) to CEM as well as HGF-induced trans-EC electrical resistance. In addition, silencing Tiam1 or dynamin 2 reduced HGF-induced Rac1 activation, cortactin recruitment to CEM, and EC barrier regulation. We observed that both HGF- and high molecular weight hyaluronan (CD44 ligand)-mediated protection from lipopolysaccharide-induced pulmonary vascular hyperpermeability was significantly reduced in CD44 knock-out mice, thus validating these in vitro findings in an in vivo murine model of inflammatory lung injury. Taken together, these results suggest that CD44 is an important regulator of HGF/c-Met-mediated in vitro and in vivo barrier enhancement, a process with essential involvement of Tiam1, Rac1, dynamin 2, and cortactin.",
author = "Singleton, {Patrick A.} and Ravi Salgia and Liliana Moreno-Vinasco and Jaideep Moitra and Saad Sammani and Tamara Mirzapoiazova and Garcia, {Joe GN}",
year = "2007",
month = "10",
day = "19",
doi = "10.1074/jbc.M702573200",
language = "English (US)",
volume = "282",
pages = "30643--30657",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "42",

}

TY - JOUR

T1 - CD44 regulates hepatocyte growth factor-mediated vascular integrity

T2 - Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin

AU - Singleton, Patrick A.

AU - Salgia, Ravi

AU - Moreno-Vinasco, Liliana

AU - Moitra, Jaideep

AU - Sammani, Saad

AU - Mirzapoiazova, Tamara

AU - Garcia, Joe GN

PY - 2007/10/19

Y1 - 2007/10/19

N2 - The preservation of vascular endothelial cell (EC) barrier integrity is critical to normal vessel homeostasis, with barrier dysfunction being a feature of inflammation, tumor angiogenesis, atherosclerosis, and acute lung injury. Therefore, agents that preserve or restore vascular integrity have important therapeutic implications. In this study, we explored the regulation of hepatocyte growth factor (HGF)-mediated enhancement of EC barrier function via CD44 isoforms. We observed that HGF promoted c-Met association with CD44v10 and recruitment of c-Met into caveolin-enriched microdomains (CEM) containing CD44s (standard form). Treatment of EC with CD44v10-blocking antibodies inhibited HGF-mediated c-Met phosphorylation and c-Met recruitment to CEM. Silencing CD44 expression (small interfering RNA) attenuated HGF-induced recruitment of c-Met, Tiam1 (a Rac1 exchange factor), cortactin (an actin cytoskeletal regulator), and dynamin 2 (a vesicular regulator) to CEM as well as HGF-induced trans-EC electrical resistance. In addition, silencing Tiam1 or dynamin 2 reduced HGF-induced Rac1 activation, cortactin recruitment to CEM, and EC barrier regulation. We observed that both HGF- and high molecular weight hyaluronan (CD44 ligand)-mediated protection from lipopolysaccharide-induced pulmonary vascular hyperpermeability was significantly reduced in CD44 knock-out mice, thus validating these in vitro findings in an in vivo murine model of inflammatory lung injury. Taken together, these results suggest that CD44 is an important regulator of HGF/c-Met-mediated in vitro and in vivo barrier enhancement, a process with essential involvement of Tiam1, Rac1, dynamin 2, and cortactin.

AB - The preservation of vascular endothelial cell (EC) barrier integrity is critical to normal vessel homeostasis, with barrier dysfunction being a feature of inflammation, tumor angiogenesis, atherosclerosis, and acute lung injury. Therefore, agents that preserve or restore vascular integrity have important therapeutic implications. In this study, we explored the regulation of hepatocyte growth factor (HGF)-mediated enhancement of EC barrier function via CD44 isoforms. We observed that HGF promoted c-Met association with CD44v10 and recruitment of c-Met into caveolin-enriched microdomains (CEM) containing CD44s (standard form). Treatment of EC with CD44v10-blocking antibodies inhibited HGF-mediated c-Met phosphorylation and c-Met recruitment to CEM. Silencing CD44 expression (small interfering RNA) attenuated HGF-induced recruitment of c-Met, Tiam1 (a Rac1 exchange factor), cortactin (an actin cytoskeletal regulator), and dynamin 2 (a vesicular regulator) to CEM as well as HGF-induced trans-EC electrical resistance. In addition, silencing Tiam1 or dynamin 2 reduced HGF-induced Rac1 activation, cortactin recruitment to CEM, and EC barrier regulation. We observed that both HGF- and high molecular weight hyaluronan (CD44 ligand)-mediated protection from lipopolysaccharide-induced pulmonary vascular hyperpermeability was significantly reduced in CD44 knock-out mice, thus validating these in vitro findings in an in vivo murine model of inflammatory lung injury. Taken together, these results suggest that CD44 is an important regulator of HGF/c-Met-mediated in vitro and in vivo barrier enhancement, a process with essential involvement of Tiam1, Rac1, dynamin 2, and cortactin.

UR - http://www.scopus.com/inward/record.url?scp=35648962884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648962884&partnerID=8YFLogxK

U2 - 10.1074/jbc.M702573200

DO - 10.1074/jbc.M702573200

M3 - Article

VL - 282

SP - 30643

EP - 30657

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 42

ER -